(202 days)
The ComfortLite 2 Nasal Mask is intended to provide an interface for Continuous Positive Airway Pressure (CPAP) or bi-level therapy. This mask is intended for single-patient reuse in the home and multi-patient, multi-use in the hospital/institutional environment. This mask is to be used on patients greater than 66 lbs / 30 kg.
The ComfortLite™ Nasal Mask is unchanged from the device design submitted and cleared in K053352. The Comfortlite Nasal Mask designed for patients ( > 66 Ibs / 30 kg ) as a nasal interface for application of non-invasive CPAP or bi-level therapy. It consists of a nasal interface with a built-in exhalation device, interface adjustment mechanisms, and 6" of standard 22 mm tubing connected to a crown swivel (elbow) for connection to the CPAP or Bi-level device. The mask is supported by a baseball-cap type headgear to allow a seal with the patient's nostrils via the nasal interface. Three types of nasal cushions are compatible with the base frame structure that comes in one frame size. These include a simple cushion, a direct seal cushion, and nasal pillows. All nasal interfaces are available in multiple sizes to meet the needs of the user.
The provided text describes a 510(k) summary for the ComfortLite™ Nasal Mask, focusing on its substantial equivalence to a predicate device and its intended use, particularly the inclusion of a multi-patient re-use claim. The performance data section refers to "Mask Efficacy Testing" to confirm the efficacy of cleaning methods.
However, the document does not contain specific details for many of the requested categories related to medical device AI/ML performance studies, as it describes a physical medical device (nasal mask) and not an AI or algorithm-driven diagnostic or therapeutic device. The "acceptance criteria" discussed are in the context of design verification tests, not a clinical performance study with statistical metrics for an AI system.
Here's the breakdown based on the provided text, and where information is missing (which is most categories, given the nature of the device):
1. Table of Acceptance Criteria and Reported Device Performance
The document mentions "Design verification tests were performed on the ComfortLite™ Nasal Mask... All tests were verified to meet the required acceptance criteria." and "The results of the testing confirm that exposure to the specified cleaning, and disinfection agents do not degrade the performance of the ComfortLite Nasal Mask as it was originally cleared in K053352."
However, it does not provide a specific table of acceptance criteria and reported device performance for a clinical or algorithmic study, as it is a physical device submission focused on material integrity and cleaning efficacy.
| Acceptance Criteria | Reported Device Performance |
|---|---|
| Not specified in detail for a clinical/algorithmic study. The general criterion is that cleaning and disinfection do not degrade performance. | Not specified with quantitative metrics. The document states "confirm that exposure to the specified cleaning, and disinfection agents do not degrade the performance of the ComfortLite Nasal Mask". |
2. Sample Size Used for the Test Set and Data Provenance
This information is not provided in the document. The testing described focuses on material/cleaning efficacy, not on a patient test set for an AI or diagnostic algorithm.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications
This information is not provided. The ground truth relevant to this device would be the physical integrity and cleanliness post-processing, established by technical testing methods, not by human experts interpreting data.
4. Adjudication Method for the Test Set
This information is not provided.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done
No, an MRMC study was not done. This type of study is relevant for diagnostic performance of AI algorithms where human readers are involved. This submission is for a physical medical device.
6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was Done
No, a standalone algorithm performance study was not done. This device is a physical mask for CPAP/bi-level therapy.
7. The Type of Ground Truth Used
The ground truth implicitly used for the "Mask Efficacy Testing" and design verification would be technical measurements of material degradation, structural integrity, and cleanliness after exposure to cleaning/disinfection agents. This is not "expert consensus," "pathology," or "outcomes data" in the typical sense of a diagnostic device.
8. The Sample Size for the Training Set
This information is not provided and is not applicable to a physical device submission of this nature. "Training set" is a concept for machine learning models.
9. How the Ground Truth for the Training Set was Established
This information is not provided and is not applicable.
{0}------------------------------------------------
TAB 5
510(K) SUMMARY
Date of Submission
August 28, 2008
Official Contact / Address of Manufacturing facility
Andrew P. Zeltwanger Manager, Regulatory Affairs Respironics Inc. 1740 Golden Mile Highway Monroeville, PA 15146
Phone: 724-387-7442 Fax: 724-387-7490 Andrew.zeltwanger@Respironics.com
| Proprietary Name | ComfortLiteTM Nasal Mask |
|---|---|
| Common/Usual Name | Nasal Mask |
| Device Classification Name | Mask, Ventilator, Non-Continuous, Reprocessed |
| Classification Reference | 21 CFR 868.5905 |
| Classification | Class II |
| Appropriate Classification Panel | Anesthesiology |
| Product Code | BZD |
| Predicate Devices | Respironics ComfortLite Nasal Mask (K053352) |
| Reason for submission | Include a multi-patient re-use claim |
{1}------------------------------------------------
Substantial Equivalence
The modified device has the following similarities to the previously cleared device:
- O Same design
- D Same operating principle.
- Same technology.
- D Same manufacturing process.
Design verification tests were performed on the ComfortLite™ Nasal Mask as a result of the risk analysis and product requirements. All tests were verified to meet the required acceptance criteria. Respironics has determined that the modifications have no impact on the safety and effectiveness of the device. In summary, the device described in this submission is substantially equivalent to the predicate device.
Intended Use
The ComfortLite 2 Nasal Mask is intended to provide an interface for Continuous Positive Airway Pressure (CPAP) or bi-level therapy. This mask is intended for single-patient reuse in the home and multi-patient, multi-use in the hospitalinstitutional environment. This mask is to be used on patients greater than 66 lbs / 30 kg.
Device Description
The ComfortLite™ Nasal Mask is unchanged from the device design submitted and cleared in K053352. The Comfortlite Nasal Mask designed for patients ( > 66 Ibs / 30 kg ) as a nasal interface for application of non-invasive CPAP or bi-level therapy. It consists of a nasal interface with a built-in exhalation device, interface adjustment mechanisms, and 6" of standard 22 mm tubing connected to a crown swivel (elbow) for connection to the CPAP or Bi-level device. The mask is supported by a baseball-cap type headgear to allow a seal with the patient's nostrils via the nasal interface. Three types of nasal cushions are compatible with the base frame structure that comes in one frame size. These include a simple cushion, a direct seal cushion, and nasal pillows. All nasal interfaces are available in multiple sizes to meet the needs of the user.
Performance Data:
Performance testing has been carried out to verily the safety and effectiveness of the ComfortLite Nasal Mask with all cushion types. The results of the testing confirm that exposure to the specified
{2}------------------------------------------------
cleaning, and disinfection agents do not degrade the performance of the ComfortLite Nasal Mask as it was originally cleared in K053352. Test data is provided in Tab 18A of this submission.
Mask Efficacy Testing
All mask materials that come in contact with the specified cleaning and disinfection agents have been tested by an independent laboratory to confirm efficacy of the cleaning methods specified in the ComfortLite Nasal Mask Cleaning and Disinfection guide. The details are specified in Tab 14 of his submission.
(End of Tab.)
{3}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes representing the department's three main goals: health, human services, and well-being. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES. USA" are arranged in a circular pattern around the eagle.
MAR 2 5 2009
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Respironics, Incorporated Mr. Andrew P. Zeltwanger Manager, Regulatory Affairs Sleep & Home Respiratory Group 1740 Golden Mile Highway Monroeville, Pennsylvania 15146
Re: K082558
Trade/Device Name: ComfortLite™ Nasal Mask Regulation Number: 21 CFR 868.5905 Regulation Name: Noncontinuous Ventilator (IPPB) Regulatory Class: II Product Code: BZD Dated: February 27, 2009 Received: March 2, 2009
Dear Mr. Zeltwanger:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device ' Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{4}------------------------------------------------
Page 2 - Mr. Zeltwanger
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Susan Runne
Ginette Y. Michaud, M.D. Acting Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
Indications for Use
510(k) Number (if known): K082558
ComfortLite 100 Nasal Mask Device Name:
Indications for Use:
The ComfortLite 2 Nasal Mask is intended to provide an interface for Continuous Positive Airway Pressure (CPAP) or bi-level therapy. This mask is intended for single-patient reuse in the home and multi-patient, multi-use in the hospital/institutional environment. This mask is to be used on patients greater than 66 lbs / 30 kg.
Prescription Use _ × Over-The-Counter Use Prescription Ose _____________________________________________________________________________________________________________________________________________________________ (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Susan Runner
(Division Sign-Off) nivision of Anestheslology. General Hospital fection Control, Dental Devices
510(k) Number: K082558
§ 868.5905 Noncontinuous ventilator (IPPB).
(a)
Identification. A noncontinuous ventilator (intermittent positive pressure breathing-IPPB) is a device intended to deliver intermittently an aerosol to a patient's lungs or to assist a patient's breathing.(b)
Classification. Class II (performance standards).